SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QDEL - Quidel more quick diagnosis
QDEL 22.60+3.2%Nov 12 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Clarksterh who wrote (1357)1/24/1998 11:35:00 PM
From: Robert Busse  Read Replies (2) of 1693
 
Clark, Dr Pronovost's new employer is Pacific Biometrics, a different company than Pacific Biotech which Quidel bought from Eli Lilly a few years ago - re the CC and the nitwit analyst who kept pestering Mr Frankel for dates and specifics of an acquisition, I agree w/ you that Mr Frankel's reluctance to answer his stupid questions makes me think something is in the works - Think about it - the analyst himself asked about Mr DeBruin's coming on board at Qdel - The way I see it, Mr deBruin was obviously brought there for a reason-why?? to increase sales and get the stock price up-if you look at his employment contract w/ Qdel (contained in SEC filings) you can see it is full of stock options up to $15/ share - DeBruin was once the CEO of a 3 billion company, Boehringer Mannheim, and BM is in my opinion the most likely source from which Qdel may acquire a new product line. BM is currently merging (or actually being taken over) by Roche, although final approval has not yet been given for the deal - I think the EU is expected to give the deal its seal of approval in mid-February - I strongly suspect any deal between Qdel and BM will have to wait till the BM/Roche announcement before it can be announced. All of this is public info available to anyone willing to do the research - I may be dead wrong about all of this but it sure seems like the most likely scenario - Why then can't that analyst figure this out and also figure that, if true, Mr Frankel simply can't comment on such a deal - It doesn't seem like brain surgery to me - I for one am keeping my eye on YaHoo for the next press release. Time will tell. BOB
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext